Over three years after the outbreak of the COVID-19 pandemic, biosafety experts told the House what steps might reduce the likelihood of a similar disaster.
“We still do not know how the COVID-19 pandemic started. However, more information has heightened our suspicions that the origin of the pandemic was linked to a lab incident,” said Rep. Cathy McMorris Rodgers (R-Wash.), chair of the House Energy and Commerce Committee, in her opening statement at an April 27 hearing of that committee’s oversight subcommittee.
Yet, official opinions have shifted.
Subcommittee Chair Morgan Griffith (R-Va.) said in his opening statement that NIH has “stonewalled and slow-walked our document requests related to Ecohealth Alliance grants.”
While Republicans criticized the NIH, Democrats used their opening remarks to defend America’s major federal scientific institutions.
“We also need to discuss the training and safety measures that are already in place in high-containment labs to reduce risk,” said Rep. Frank Pallone (D-N.J.), the committee’s ranking member.
“We have seen scientists, including some of our top public health officials, maligned, marginalized, taken out of context, and accused of covering up the origins of COVID-19,” he said.
Subcommittee Ranking Member Kathy Castor (D-Fla.) suggested that some proposals floated by Republicans could undercut America’s global leadership on science.
US vs World
Gregory Koblentz, an associate professor and biodefense expert at George Mason University, detailed the United States’ performance on biosafety and biosecurity in written testimony.On biosafety–the specific practices used to handle biological agents at minimal risk–the United States does well, along with most other countries Koblentz studied.
On biosecurity–the steps taken to “protect microbial agents from loss, theft, diversion or intentional misuse”–the U.S. is tied for #1, but the global picture is grimmer.
“Only 12 out of the 27 countries with BSL-4 labs scored high, with nine countries scoring medium and six low,” Koblentz testified.
BSL-4 (biosafety level 4) laboratories are at the top of the biosafety hierarchy. They handle deadly pathogens, including the Ebola virus and the Marburg virus.
China’s first BSL-4 lab was the Wuhan Institute of Virology.
Castor asked Koblentz if greater cooperation with the World Health Organization (WHO) is the right strategy for addressing risks from laboratories outside the United States.
He recommended what he called a “two-pronged approach.”
“Working through organizations like the WHO and the Biological Weapons Convention can enable us to set international standards,” he said.
Independent Agency Recommended
Koblentz told Griffith biosafety and biosecurity at America’s research facilities could potentially be managed by an independent agency, perhaps similar to the Nuclear Regulatory Commission.Both he and Rocco Casagrande, board chair of Gryphon Scientific, said that a database compiling near misses would also be helpful.
Rep. Michael Burgess (R-Texas), a medical doctor, questioned another expert, Bob Hawley, along similar lines.
Hawley once led the Safety and Radiation Protection Division at Fort Detrick, the hub of America’s biodefense research program.
Hawley called for “a national database so that we can all share and learn from what happened without any negative consequences.”
In written testimony, he cited the National Transportation Safety Board Aviation Accident Database and Synopses database as one of several possible models.
He counseled against an overly punitive approach.
The threat of punishment for alerting others to a near miss “has a tendency to drive these incidents underground, so they’re never reported,” he said.
“I think that is so important,” Burgess said.
“Maybe that could have avoided some of the difficulties that we see now with EcoHealth Alliance,” he added.